Jul 15, 2026 07:40AM

Jul 14, 2026 07:32AM

Jul 13, 2026 06:40AM

Jul 9, 2026 06:53AM

Jul 6, 2026 05:05PM

Jun 10, 2026 05:02PM

Mar 19, 2026 07:31AM CervoMed shares new data showing drug benefits for dementia patients

Mar 17, 2026 06:48AM

Feb 18, 2026 06:02AM

Dec 18, 2025 06:34AM

Dec 4, 2025 05:00PM

Dec 2, 2025 07:01AM

Nov 5, 2025 06:15AM

Nov 4, 2025 07:00AM CervoMed gains FDA alignment for dementia with Lewy bodies drug trial

Oct 28, 2025 08:03AM

Oct 8, 2025 07:00AM

Oct 7, 2025 08:01AM

Aug 11, 2025 07:03AM

Jul 29, 2025 07:20AM

Jul 28, 2025 07:01AM

May 13, 2025 06:20AM CervoMed (CRVO) Misses Q1 EPS by 56c

May 12, 2025 03:57PM

Mar 13, 2025 11:23AM

Mar 12, 2025 04:39PM

Mar 11, 2025 08:20AM

Feb 19, 2025 07:05AM

Jan 31, 2025 08:03AM

Dec 11, 2024 06:38AM CervoMed (CRVO) PT Lowered to $12 at Canaccord Genuity

Dec 11, 2024 05:19AM

Dec 11, 2024 02:32AM

Dec 10, 2024 11:37AM

Dec 10, 2024 08:23AM

Dec 10, 2024 07:02AM

Dec 6, 2024 08:43AM

Nov 27, 2024 07:02AM CervoMed (CRVO) Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia

Nov 18, 2024 07:16AM

Nov 13, 2024 08:00AM

Nov 12, 2024 07:42AM

Oct 3, 2024 05:15PM

Sep 18, 2024 05:17AM

Aug 12, 2024 09:51AM

Jul 29, 2024 08:08AM CervoMed (CRVO) Announces Presentation at AAIC 2024 on Plasma Biomarker Data That Are Consistent with Neflamapimod Impacting the Underlying Disease Process in Patients with DLB

Jul 26, 2024 03:45AM

Jul 24, 2024 07:45AM

Jul 8, 2024 09:04AM

418,321 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All